Neurodegeneration with brain iron accumulation (NBIA)

Symptoms of NBIA begin in childhood or adulthood.

There are 10 types of NBIA. Each type is caused by a different gene defect. The most common gene defect causes the disorder called PKAN (pantothenate kinase-associated neurodegeneration).

People with all forms of NBIA have a buildup of iron in the basal ganglia. This is an area deep inside the brain. It helps control movement.

NBIA mainly causes movement problems. Other symptoms may include:

• Dementia
• Difficulty speaking
• Difficulty swallowing
• Muscle problems such as rigidity or involuntary muscle contractions (dystonia)
• Seizures
• Tremor
• Vision loss, such as from retinitis pigmentosa
• Weakness
• Writhing movements
• Toe walking

The health care provider will perform a physical exam and ask about symptoms and medical history.

Genetic tests can look for the defective gene that causes the disease. However, these tests aren't widely available.

Tests such as an MRI scan can help rule out other movement disorders and diseases. The MRI usually shows iron deposits in the basal ganglia, and are called the "eye of the tiger" sign because of the way the deposits look in the scan. This sign suggests a diagnosis of PKAN.

There is no specific treatment for NBIA. Medicines that bind iron may help slow the disease. Treatment is mainly focused on controlling the symptoms.

NBIA gets worse and damages the nerves over time. It leads to a lack of movement, and often death by early adulthood.

Medicine used to treat symptoms can cause complications. Being unable to move from the disease can lead to:

• Blood clots
• Respiratory infections
• Skin breakdown

Call your provider if your child develops:

• Increased stiffness in the arms or legs
• Increasing problems at school
• Unusual movements

Genetic counseling may be recommended for families affected by this illness. There is no known way to prevent it.

Hallervorden-Spatz disease; Pantothenate kinase-associated neurodegeneration; PKAN; NBIA

Gregory A, Hayflick S. Neurodegeneration with brain iron accumulation disorders overview. In: Pagon RA, Adam MP, Ardinger HH, et al, eds. GeneReviews. Seattle (WA): University of Washington, Seattle; 1993-2016. Updated April 24, 2014. www.ncbi.nlm.nih.gov/books/NBK121988. Accessed July 29, 2016.

Jankovic J. Parkinson disease and other movement disorders. In: Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL, eds. Bradley's Neurology in Clinical Practice. 7th ed. Philadelphia, PA: Elsevier; 2016:chap 96.

NBIA Disorders Association. Overview of NBIA Disorders. NBIAdisorders.org. www.nbiadisorders.org/about-nbia/overview-of-nbia-disorders. Accessed July 29, 2016.

Updated by: Amit M. Shelat, DO, FACP, Attending Neurologist and Assistant Professor of Clinical Neurology, SUNY Stony Brook, School of Medicine, Stony Brook, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.